Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
/PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical...
United States Minmin Sun Tianhang Luo First Affiliated Hospital Of Zhejiang University Suzhou Immunofoco Biotechnology Co Ltd American Society Of Clinical Oncology
Source: prnewswire.com